PMV Pharmaceuticals, Inc. - 8-K Filing
PMV Pharmaceuticals appoints Dr. Matthew Eckler to its board with equity compensation package as it prepares NDA submission for rezatapopt in Q1 2027. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)
Tickers: $PMVP